Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Hui Hui
Institution:
Sanford Burnham Prebys Medical Discovery Institute
Observed institution:
Sanford Burnham Prebys Medical Discovery Institute
ORCID:
0009-0001-0642-1522
Observed ORCID:
0009-0001-0642-1522
OpenAlex ID:
A5113263273
Extrachromosomal DNA–Driven Oncogene Dosage Heterogeneity Promotes Rapid Adaptation to Therapy in MYCN -Amplified Cancers
2025
·
Giulia Montuori
, Fengyu Tu
, et al.
·
Cancer Discovery
·
29
Figure S2 from Extrachromosomal DNA–Driven Oncogene Dosage Heterogeneity Promotes Rapid Adaptation to Therapy in MYCN-Amplified Cancers
2025
·
Giulia Montuori
, Fengyu Tu
, et al.
PDF
Figure S5 from Extrachromosomal DNA–Driven Oncogene Dosage Heterogeneity Promotes Rapid Adaptation to Therapy in MYCN-Amplified Cancers
2025
·
Giulia Montuori
, Fengyu Tu
, et al.
Figure S4 from Extrachromosomal DNA–Driven Oncogene Dosage Heterogeneity Promotes Rapid Adaptation to Therapy in MYCN-Amplified Cancers
2025
·
Giulia Montuori
, Fengyu Tu
, et al.
PDF
Table S4 from Extrachromosomal DNA–Driven Oncogene Dosage Heterogeneity Promotes Rapid Adaptation to Therapy in MYCN-Amplified Cancers
2025
·
Giulia Montuori
, Fengyu Tu
, et al.
Table S2 from Extrachromosomal DNA–Driven Oncogene Dosage Heterogeneity Promotes Rapid Adaptation to Therapy in MYCN-Amplified Cancers
2025
·
Giulia Montuori
, Fengyu Tu
, et al.
Table S3 from Extrachromosomal DNA–Driven Oncogene Dosage Heterogeneity Promotes Rapid Adaptation to Therapy in MYCN-Amplified Cancers
2025
·
Giulia Montuori
, Fengyu Tu
, et al.
Data from Extrachromosomal DNA–Driven Oncogene Dosage Heterogeneity Promotes Rapid Adaptation to Therapy in MYCN-Amplified Cancers
2025
·
Giulia Montuori
, Fengyu Tu
, et al.
Figure S1 from Extrachromosomal DNA–Driven Oncogene Dosage Heterogeneity Promotes Rapid Adaptation to Therapy in MYCN-Amplified Cancers
2025
·
Giulia Montuori
, Fengyu Tu
, et al.
PDF
Figure S7 from Extrachromosomal DNA–Driven Oncogene Dosage Heterogeneity Promotes Rapid Adaptation to Therapy in MYCN-Amplified Cancers
2025
·
Giulia Montuori
, Fengyu Tu
, et al.
Table S1 from Extrachromosomal DNA–Driven Oncogene Dosage Heterogeneity Promotes Rapid Adaptation to Therapy in MYCN-Amplified Cancers
2025
·
Giulia Montuori
, Fengyu Tu
, et al.
Figure S6 from Extrachromosomal DNA–Driven Oncogene Dosage Heterogeneity Promotes Rapid Adaptation to Therapy in MYCN-Amplified Cancers
2025
·
Giulia Montuori
, Fengyu Tu
, et al.
PDF
Figure S3 from Extrachromosomal DNA–Driven Oncogene Dosage Heterogeneity Promotes Rapid Adaptation to Therapy in MYCN-Amplified Cancers
2025
·
Giulia Montuori
, Fengyu Tu
, et al.
Figure S8 from Extrachromosomal DNA–Driven Oncogene Dosage Heterogeneity Promotes Rapid Adaptation to Therapy in MYCN-Amplified Cancers
2025
·
Giulia Montuori
, Fengyu Tu
, et al.
PDF
Show more works
View as search
Works count:
14
Citation count:
29
H-index:
1
I10-index:
1
Year
Topic
Type